Back to Search Start Over

Nektar Therapeutics Announces Multiple Presentations for Rezpegaldesleukin at EADV 2024

Source :
PR Newswire. September 25, 2024
Publication Year :
2024

Abstract

- New proteomic analyses show that rezpegaldesleukin increases the protein levels of immune-regulating pathways while reducing specific serum proteins known to be elevated in patients with atopic dermatitis - SAN [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
PR Newswire
Publication Type :
News
Accession number :
edsgcl.809865466